المؤلفون: Michal Schnaider Beeri, James Schmeidler, Neil B. Alexander, Mary Sano, Pearl G. Lee, Jeremy M. Silverman, Rebecca K. West, Martina Nabozny, Carolina Rodriguez Alvarez, Elizabeth Guerrero-Berroa

المصدر: Alzheimer's & Dementia : Translational Research & Clinical Interventions

مصطلحات موضوعية: 0301 basic medicine, Diabetes duration, Type 2 diabetes, Protected survivor, 03 medical and health sciences, 0302 clinical medicine, Time at risk, medicine, Risk factor, 10. No inequality, Association (psychology), business.industry, Cognition, Featured Article, medicine.disease, Executive functions, Psychiatry and Mental health, Protective factors, 030104 developmental biology, Risk factors, Hemoglobin A1c, Cognitive function, Neurology (clinical), Hemoglobin, business, 030217 neurology & neurosurgery, Demography

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4981037863900159e2b78bb61d801972Test
https://doi.org/10.1016/j.trci.2019.11.009Test

المؤلفون: Silverman, Jeremy M., Schmeidler, James, Lee, Pearl G., Alexander, Neil B., Beeri, Michal Schnaider, Guerrero‐berroa, Elizabeth, West, Rebecca K., Sano, Mary, Nabozny, Martina, Rodriguez Alvarez, Carolina

مصطلحات موضوعية: Protective factors, Protected survivor, Type 2 diabetes, Hemoglobin A1c, Cognitive function, Risk factors, Diabetes duration, Neurology and Neurosciences, Health Sciences

وصف الملف: application/pdf

العلاقة: Silverman, Jeremy M.; Schmeidler, James; Lee, Pearl G.; Alexander, Neil B.; Beeri, Michal Schnaider; Guerrero‐berroa, Elizabeth; West, Rebecca K.; Sano, Mary; Nabozny, Martina; Rodriguez Alvarez, Carolina (2019). "Associations of hemoglobin A1c with cognition reduced for long diabetes duration." Alzheimer’s & Dementia: Translational Research & Clinical Interventions 5(C): 926-932.; https://hdl.handle.net/2027.42/152553Test; Alzheimer’s & Dementia: Translational Research & Clinical Interventions; M.F. Folstein, S.E. Folstein, and P.R. McHugh. Mini Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12: 1975; 189 â 198; K. Mattishent, and Y.K. Loke. Biâ directional interaction between hypoglycaemia and cognitive impairment in elderly patients treated with glucoseâ lowering agents: a systematic review and metaâ analysis. Diabetes Obes Metab. 18: 2016; 135 â 141; Z. Punthakee, M.E. Miller, L.J. Launer, J.D. Williamson, R.M. Lazar, and T. Cukiemanâ Yaffee, et al. Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. Diabetes Care. 35: 2012; 787 â 793; D.G. Bruce, W.A. Davis, G.P. Casey, S.E. Starkstein, R.M. Clarnette, and J.K. Foster, et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia. 51: 2008; 241 â 248; K. Pal, N. Mukadam, I. Petersen, and C. Cooper. Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and metaâ analysis. Soc Psychiatry Psychiatr Epidemiol. 53: 2018; 1149 â 1160; G. Li, J.B. Shofer, W.A. Kukull, E.R. Peskind, D.W. Tsuang, and J.C. Breitner, et al. Serum cholesterol and risk of Alzheimer disease: a communityâ based cohort study. Neurology. 65: 2005; 1045 â 1050; E. van den Berg, G.J. Biessels, A.J. de Craen, J. Gussekloo, and R.G. Westendorp. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology. 69: 2007; 979 â 985; M.M. Mielke, P.P. Zandi, M. Sjogren, D. Gustafson, S. Ostling, and B. Steen, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology. 64: 2005; 1689 â 1695; T.A. Lima, A.L. Adler, T. Minett, F.E. Matthews, C. Brayne, and R.E. Marioni, et al. Câ reactive protein, APOE genotype and longitudinal cognitive change in an older population. Age Ageing. 43: 2014; 289 â 292; S.M. Euser, B.T. Van, M.T. Schram, J. Gussekloo, A. Hofman, and R.G. Westendorp, et al. The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc. 57: 2009; 1232 â 1237; M.S. Beeri, R. Ravonaâ Springer, J.M. Silverman, and V. Haroutunian. The effects of cardiovascular risk factors on cognitive compromise. Dialogues Clin Neurosci. 11: 2009; 201 â 212; J.M. Silverman, and J. Schmeidler. The protected survivor model: Using resistant successful cognitive aging to identify protection in the very old. Med Hypotheses. 110: 2018; 9 â 14; R. West, M.S. Beeri, J. Schmeidler, C. Hannigan, G. Angelo, and C. Rosendorff, et al. Better memory functioning associated with higher total and LDL cholesterol levels in very elderly subjects without the APOE4 allele. Am J Geriatr Psychiatry. 16: 2008; 781 â 785; J. Huang, J. Schmeidler, M.S. Beeri, C. Rosendorff, S. Bhatia, and R.K. West, et al. Haemoglobin A(1c) and cognitive function in very old, cognitively intact men. Age Ageing. 41: 2012; 125 â 128; J.M. Silverman, M.S. Beeri, J. Schmeidler, C. Rosendorff, G. Angelo, and R.S. Mavris, et al. Câ reactive protein and memory function suggest antagonistic pleiotropy in very old nondemented subjects. Age Ageing. 38: 2009; 237 â 241; R. Ravonaâ Springer, E. Moshier, J. Schmeidler, J. Godbold, J. Akrivos, and M. Rapp, et al. Changes in glycemic control are associated with changes in cognition in nonâ diabetic elderly. J Alzheimers Dis. 30: 2012; 299 â 309; E. Dybjer, P.M. Nilsson, G. Engstrom, C. Helmer, and K. Nagga. Preâ diabetes and diabetes are independently associated with adverse cognitive test results: a crossâ sectional, populationâ based study. BMC Endocr Disord. 18: 2018; 91; F. Zheng, L. Yan, Z. Yang, B. Zhong, and W. Xie. HbA1c, diabetes and cognitive decline: the English Longitudinal Study of Ageing. Diabetologia. 61: 2018; 839 â 848; M. Karran, E. Guerreroâ Berroa, J. Schmeidler, P.G. Lee, N. Alexander, and M. Nabozny, et al. Recruitment of older veterans with diabetes risk for Alzheimer’s disease for a randomized clinical trial of computerized cognitive training. J Alzheimers Dis. 69: 2019; 401 â 411; M. Heisler, D.M. Smith, R.A. Hayward, S.L. Krein, and E.A. Kerr. How well do patients’ assessments of their diabetes selfâ management correlate with actual glycemic control and receipt of recommended diabetes services?. Diabetes Care. 26: 2003; 738 â 743; J.C. Morris. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 9: 1997; 173 â 176; E. Guerreroâ Berroa, R. Ravonaâ Springer, J. Schmeidler, J.M. Silverman, M. Sano, and K. Koifman, et al. Age, gender, and education are associated with cognitive performance in an older Israeli sample with type 2 diabetes. Int J Geriatr Psychiatry. 29: 2014; 299 â 309; VA Information Technology. History of IT at VA. 2016; Department of Veterans Affairs, https://www.oit.va.gov/about/history.cfm#2016STest; J.M. Silverman, and J. Schmeidler. Outcome ageâ based prediction of successful cognitive aging by total cholesterol. Alzheimers Dement. 14: 2018; 952 â 960; C. Reitz, M.X. Tang, J. Manly, N. Schupf, R. Mayeux, and J.A. Luchsinger. Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment. Dement Geriatr Cogn Disord. 25: 2008; 232 â 237; T.M. van Himbergen, A.S. Beiser, M. Ai, S. Seshadri, S. Otokozawa, and R. Au, et al. Biomarkers for insulin resistance and inflammation and the risk for allâ cause dementia and alzheimer disease: results from the Framingham Heart Study. Arch Neurol. 69: 2012; 594 â 600; D. Valerio, H. Raventos, J. Schmeidler, M.S. Beeri, L.M. Villalobos, and P. Bolanosâ Palmieri, et al. Association of apolipoprotein Eâ e4 and dementia declines with age. Am J Geriatr Psychiatry. 22: 2014; 957 â 960; J.R. Carrionâ Baralt, J. Melendezâ Cabrero, H. Rodriguezâ Ubinas, J. Schmeidler, M.S. Beeri, and G. Angelo, et al. Impact of APOE epsilon4 on the cognitive performance of a sample of nonâ demented Puerto Rican nonagenarians. J Alzheimers Dis. 18: 2009; 533 â 540; T. Cukiermanâ Yaffe, H.C. Gerstein, J.D. Williamson, R.M. Lazar, L. Lovato, and M.E. Miller, et al. Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetesâ memory in diabetes (ACCORDâ MIND) trial. Diabetes Care. 32: 2009; 221 â 226; H.C. Gerstein, M.E. Miller, R.P. Byington, D.C. Goff, J.T. Bigger, and J.B. Buse, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 358: 2008; 2545 â 2559; B.L. Plassman, J.W. Williams Jr., J.R. Burke, T. Holsinger, and S. Benjamin. Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life. Ann Intern Med. 153: 2010; 182 â 193; M. Samson, F. Libert, B.J. Doranz, J. Ruker, C. Liesnard, and C.M. Farber, et al. Resistance to HIVâ 1 infection in caucasian individuals bearing mutant alleles of the CCRâ 5 chemokine receptor gene [see comments]. Nature. 382: 1996; 722 â 725; National Center for Chronic Disease Prevention and Health Promotion Division of Diabetes Translation. National Diabetes Statistics Report, 2017. Estimates of Diabetes and Its Burden in the United States. 2017; Center for Disease Control, https://www.cdc.gov/diabetes/pdfs/data/statistics/nationalTestâ diabetesâ statisticsâ report.pdf

الإتاحة: https://doi.org/10.1016/j.trci.2019.11.009Test
https://hdl.handle.net/2027.42/152553Test